With only one month available to purchase, the INKREDIBLE 3D bioprinter is already a succes story. With a retail price of $4,999 (including shipping), this bioprinter is the most cost effective printer available in its class. It comes standard with dual print heads and everything the customer requires to get started with bioprinting right off the bat.
The INKREDIBLE targets innovators and early adopters to make this exciting technology more affordable and available. The vision is to make sure that more and more researchers utilize this technology as it will speed up the process to reach the ultimate goal of reducing the need for donors in the transplant market while also reducing the utilization of animal studies in the pharmaceutical and cosmetology industry.
The creators of the INKREDIBLE started their company with CELLINK, a bioink that has become the most widely used bioink in the world thanks to its excellent biocompatibility, printability, and structure that ensures 98% cell viability (study made with RoosterBio cells at Chalmers University in Sweden).
Another great feature of the INKREDIBLE is its clean chamber technology. This is an option that can be added and is not included in the $4,999. The technology ensures the printing chamber (in which the bioprinting takes place) to be almost sterile, CGMP environment. The printer has a highly filtered air flow with positive pressure created inside the chamber so it reduces contamination and particle count inside the printing area basically down to zero. This means that researchers can print right on the benchtop.
Right now CELLINK is busy with preparing a major launch of new bioinks for additional applications such as skin, liver (hepatocytes) and bioinks – specified as drug delivery system so that customers can print encapsulation devices. They’re also expanding their bioprinting services to facilitate corporate and academic customers who want to expand into new bioprinting applications. The bioprinting services that CELLINK provides has been a great success for many partners and the fact that these partners can receive cell specific expertise enables for new proprietary tissue model creation for internal product development testing platforms.